Generic Name and Formulations:
Fluorometholone 0.1%; oph susp; contains benzalkonium chloride.
Alcon Laboratories, Inc.
Indications for FLAREX:
1–2 drops 4 times daily. May increase to 2 drops every 2hrs during the initial 24–48hrs. Reevaluate after 2 weeks if no improvement.
Fungal, mycobacterial, viral (except herpes zoster), or untreated bacterial infections.
Corneal or scleral thinning. Glaucoma. Monitor for secondary infections and intraocular pressure in prolonged use. Avoid abrupt cessation. May mask or exacerbate infections. Pregnancy. Nursing mothers.
Glaucoma with optic nerve damage, visual acuity and field defects, cataract formation, secondary ocular infection, perforation of the globe, delayed wound healing.
Renal and Urology News Articles
- Urine Immunoassay Identifies Novel Lupus Nephritis Biomarkers
- Novel Albuminuria Endpoints May Improve CKD Progression Trials
- Comorbidities Adversely Linked to Cancer Trial Participation
- Global Demand for Bladder Cancer Treatment Threatens Supply in 2019
- Opioids Now More Deadly for Americans Than Traffic Accidents
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)